OA08494A - Nouveaux polypeptides, leur procédé d'obtention, anticorps monoclonaux spécifiques pour ces polypeptides, et utilisation de ces polypeptides. - Google Patents

Nouveaux polypeptides, leur procédé d'obtention, anticorps monoclonaux spécifiques pour ces polypeptides, et utilisation de ces polypeptides.

Info

Publication number
OA08494A
OA08494A OA59026A OA59026A OA08494A OA 08494 A OA08494 A OA 08494A OA 59026 A OA59026 A OA 59026A OA 59026 A OA59026 A OA 59026A OA 08494 A OA08494 A OA 08494A
Authority
OA
OAPI
Prior art keywords
polypeptides
obtaining
monoclonal antibodies
antibodies specific
new
Prior art date
Application number
OA59026A
Other languages
English (en)
French (fr)
Inventor
Joyce M Zarling
Mohammed Shoyab
Hans Marquardt
Marcia B Hanson
Mario N Lioubin
Thomas Joseph Browm
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of OA08494A publication Critical patent/OA08494A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
OA59026A 1985-12-20 1986-12-19 Nouveaux polypeptides, leur procédé d'obtention, anticorps monoclonaux spécifiques pour ces polypeptides, et utilisation de ces polypeptides. OA08494A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US93528386A 1986-11-26 1986-11-26

Publications (1)

Publication Number Publication Date
OA08494A true OA08494A (fr) 1988-07-29

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59026A OA08494A (fr) 1985-12-20 1986-12-19 Nouveaux polypeptides, leur procédé d'obtention, anticorps monoclonaux spécifiques pour ces polypeptides, et utilisation de ces polypeptides.

Country Status (29)

Country Link
JP (1) JP2559035B2 (xx)
KR (1) KR920005920B1 (xx)
CN (1) CN1017626B (xx)
AT (1) AT400444B (xx)
AU (2) AU601168B2 (xx)
BE (1) BE905957A (xx)
CA (1) CA1340296C (xx)
CH (1) CH675727A5 (xx)
CY (1) CY1608A (xx)
DE (2) DE3645095C2 (xx)
DK (1) DK174094B1 (xx)
ES (1) ES2003180A6 (xx)
FI (1) FI91484C (xx)
FR (1) FR2597108B1 (xx)
GB (1) GB2185485B (xx)
GR (1) GR862936B (xx)
HK (1) HK65691A (xx)
HU (1) HU210694B (xx)
IE (1) IE59415B1 (xx)
IL (1) IL81017A (xx)
IT (1) IT1213428B (xx)
LU (1) LU86718A1 (xx)
NL (1) NL8603209A (xx)
NO (1) NO174556C (xx)
NZ (1) NZ218634A (xx)
OA (1) OA08494A (xx)
PT (1) PT83986B (xx)
SE (1) SE505059C2 (xx)
SG (1) SG60891G (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
IL97622A (en) * 1990-03-29 1997-06-10 Oncogen Limited Partnership Se Monoclonal antibodies that inhibit growth of kaposi's sarcoma
IL97623A (en) * 1990-03-29 1996-01-19 Bristol Myers Squibb Co Monoclonal antibodies against oncostatin M, their preparation and pharmaceutical preparations containing them
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
CZ195193A3 (en) * 1992-09-25 1994-04-13 Lilly Co Eli Modified factor-4 of blood platelets, process of its preparation and pharmaceutical preparation in which it is comprised

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
FR2597108A1 (fr) 1987-10-16
FR2597108B1 (fr) 1991-02-15
CH675727A5 (xx) 1990-10-31
GR862936B (en) 1987-10-28
AT400444B (de) 1995-12-27
DE3645095C2 (de) 1993-11-18
DE3643428A1 (de) 1987-09-24
SE8605459L (sv) 1987-06-21
IL81017A0 (en) 1987-03-31
CN1017626B (zh) 1992-07-29
DK174094B1 (da) 2002-06-10
CA1340296C (en) 1998-12-29
FI865156A (fi) 1987-06-21
FI865156A0 (fi) 1986-12-17
DK615386A (da) 1987-06-21
NL8603209A (nl) 1987-07-16
AU639048B2 (en) 1993-07-15
HU210694B (en) 1995-06-28
NZ218634A (en) 1991-06-25
GB8629997D0 (en) 1987-01-28
ATA340686A (de) 1995-05-15
PT83986A (en) 1987-01-01
CY1608A (en) 1992-04-03
JPS62236498A (ja) 1987-10-16
IL81017A (en) 1993-01-14
DK615386D0 (da) 1986-12-18
SE505059C2 (sv) 1997-06-16
IE863345L (en) 1987-06-20
LU86718A1 (fr) 1988-07-14
GB2185485B (en) 1990-07-04
JP2559035B2 (ja) 1996-11-27
FI91484C (fi) 1994-07-11
BE905957A (fr) 1987-06-17
SG60891G (en) 1991-08-23
KR870005645A (ko) 1987-07-06
NO174556B (no) 1994-02-14
SE8605459D0 (sv) 1986-12-18
IT8622787A0 (it) 1986-12-19
IT1213428B (it) 1989-12-20
PT83986B (pt) 1989-07-31
HK65691A (en) 1991-08-23
NO174556C (no) 1994-05-25
KR920005920B1 (ko) 1992-07-24
NO865178L (no) 1987-06-22
AU601168B2 (en) 1990-09-06
FI91484B (fi) 1994-03-31
IE59415B1 (en) 1994-02-23
AU6660886A (en) 1987-06-25
AU6776590A (en) 1991-03-14
CN86108955A (zh) 1987-12-02
ES2003180A6 (es) 1988-10-16
HUT43103A (en) 1987-09-28
GB2185485A (en) 1987-07-22
NO865178D0 (no) 1986-12-19
DE3643428C2 (xx) 1990-08-23

Similar Documents

Publication Publication Date Title
OA06717A (fr) Séquences d'ADN, molécule d'ADN recombinantes et procédé pour la production de polypeptides humains semblables aux interférons.
FR2522679B1 (fr) Procede pour la production d'anticorps monoclonaux humains
OA09198A (fr) "Comprimés de cholestyramine et procédé pour les préparer".
BE876277A (fr) Construction d'ancrage pour elements de precontrainte
DK603287D0 (da) Daaselaag af metal til daaser, hvis indhold staar under overtryk
OA08168A (fr) Anticorps monoclonaux anti-leishmania, hybridomes secréteurs de ces anti-corps, antigènes de leishmania reconnus par ces anticoprs, procédé d'obtention et applications de ces anticorps monoclonaux et de ces antigènes.
NO870649D0 (no) Fremgangsmaate for massepolymerisering av butadien.
OA08494A (fr) Nouveaux polypeptides, leur procédé d'obtention, anticorps monoclonaux spécifiques pour ces polypeptides, et utilisation de ces polypeptides.
BE888578A (fr) Composition de sec-butylbiphenyle et procede d'obtention,
OA06201A (fr) Procédé de préparation de nouveaux composés d'urée et amido .
OA07341A (fr) Nouveaux oximéthers, procédé pour leur préparation, agents contenant les nouveaux oximéthers et leur application.
PT86117A (fr) Anticorps monoclonaux antigram (-), procede de preparation et applications
FR2597010B1 (fr) Applicateur de liquide comportant un moyen perfectionne d'introduction de liquide
FR2647346B1 (fr) Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament
FR2589228B1 (fr) Dispositif d'elaboration en continu de materiaux obtenus a partir de substances a l'etat fondu
BE854703A (fr) Materiaux bitumeux teintes dans la masse notamment materiaux de couverture, de bardage ou d'etancheite et procede pour leur obtention
SE468853B (sv) Nytt lymfokin, monoklonala antikroppar specifika foer lymfokinet och deras framstaellning samt anvaendningar
FR2584418B1 (fr) Anticorps monoclonaux contre le g-interferon, hybridomes produisant de tels anticorps, procede de preparation de tels anticorps et de tels hybridomes, leur utilisation pour differencier les gifs, et ensemble ou " kit " utilisant de tels anticorps
MA20835A1 (fr) Nouveaux ortho-aminoacides, leur procede d'obtention et leurs applications
BE893174A (fr) Nouveaux aminoderives dans position 1 du 1-(3',4'-methylene-dioxyphenyl) propan-2-ol et procede pour leur preparation
FR2549726B1 (fr) Facteurs augmentant la formation d'anticorps humains et procede pour leur preparation
PT81194A (fr) Procede pour la preparation de nouveaux hydroxy-thia alcenes
MC1754A1 (fr) Nouveaux tensioactifs fluores derives de matieres proteiniques:leur procede d'obtention et leur utilisation
FR2570947B1 (fr) Anticorps monoclonaux anti-leishmania, hybridomes secreteurs de ces anticorps, antigenes de leishmania reconnus par ces anticorps, procede d'obtention et applications de ces anticorps monoclonaux et de ces antigenes
FR2599753B1 (fr) Sequence d'adn composite et son application pour la production de l'hormone de croissance